F Delva
Overview
Explore the profile of F Delva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
387
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gislard A, Gramond C, Clin B, Paris C, Delva F, Brochard P, et al.
Rev Mal Respir
. 2024 Jul;
41(7):472-487.
PMID: 39060158
Introduction: Questions concerning under-reporting of occupational diseases (OD) linked to asbestos exposure are regularly voiced in France. Monitoring of the French multicenter Asbestos-Related Disease Cohort (ARDCO), which ensures post-occupational medical...
2.
Manangama G, Migault L, Audignon-Durand S, Gramond C, Zaros C, Bouvier G, et al.
Environ Int
. 2018 Nov;
122:322-329.
PMID: 30459064
Objectives: To investigate the association between maternal occupational exposures to nanoscale particles (NPs) during pregnancy and small for gestational age (SGA). Methods: This study included 11,224 mothers and singleton birth...
3.
Migault L, Piel C, Carles C, Delva F, Lacourt A, Cardis E, et al.
Environ Int
. 2017 Dec;
112:165-173.
PMID: 29275242
Objectives: To study the relations between maternal cumulative exposure to extremely low frequency electromagnetic fields (ELF EMF) and the risk of moderate prematurity and small for gestational age within the...
4.
Delva F, Andujar P, Lacourt A, Brochard P, Pairon J
Rev Mal Respir
. 2015 Nov;
33(6):444-59.
PMID: 26572259
Objective: We aimed to review the literature regarding the dose-response relationship between occupational exposure to chemicals classified by the International Agency for Research on Cancer (IARC) as carcinogenic agents and...
5.
Delva F, Edjolo A, Peres K, Berr C, Barberger-Gateau P, Dartigues J
J Nutr Health Aging
. 2014 Sep;
18(7):698-704.
PMID: 25226109
Objectives: To describe the sequence of basic activities of daily living (ADL) loss to determine whether there is a hierarchical structure of ADL in dementia in two epidemiological prospective studies:...
6.
Delva F, Pimouguet C, Helmer C, Peres K, Brechat B, Le Goff M, et al.
Neuroepidemiology
. 2013 Apr;
41(1):20-8.
PMID: 23548733
Background/aims: This study was designed to develop a practical risk score for predicting 5-year survival after the diagnosis of dementia. Methods: Using the Paquid Study (prospective, population-based, long-term cohort study),...
7.
Delva J, Deglise S, Berard X, Dubuisson V, Delva F, Stecken L, et al.
Eur J Vasc Endovasc Surg
. 2012 Sep;
44(4):417-24.
PMID: 23017216
Objectives: The purpose of this study was to assess short- and mid-term results of in-situ revascularisation (ISR) using silver-coated Dacron prostheses and bowel repair for management of secondary aorto-enteric fistulae...
8.
Bellera C, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M, et al.
Ann Oncol
. 2012 Jan;
23(8):2166-2172.
PMID: 22250183
Background: Development of a geriatric screening tool is necessary to identify elderly cancer patients who would benefit from comprehensive geriatric assessment (CGA). We develop and evaluate the G-8 screening tool...
9.
Bui-Nguyen B, Italiano A, Delva F, Toulmond M
Bull Cancer
. 2010 Jun;
97(6):673-8.
PMID: 20547481
The main progress in the management of soft tissue sarcomas have been obtained in the field of local control. Although the main evolutive, vital, risk of these diseases is metastatic...
10.
Italiano A, Delva F, Mathoulin-Pelissier S, Le Cesne A, Bonvalot S, Terrier P, et al.
Ann Oncol
. 2010 May;
21(12):2436-2441.
PMID: 20439343
Background: The predictive value of grade for benefit from adjuvant chemotherapy (AC) in soft tissue sarcoma (STS) patients has never been explored. Patients And Methods: From 1980 to 1999, 1513...